Entry Inhibitors in HIV Therapy

1. Introduction to entry inhibitors in the management of HIV infection
John C. Tilton, Robert W. Doms

2. The challenge of HIV sequence diversity in the envelope glycoprotein
Laurence Vergne, Martine Peeters

3. Attachment of human immunodeficiency virus to cells and its inhibition
Stefan Pöhlmann, Michel J. Tremblay

4. Inhibitors that target gp120-CD4 interactions
Pin-fang Lin, John Kadow, Louis Alexander

5. Inhibitors that target gp120 interactions with coreceptor
Julie M. Strizki, Donald E. Mosier

6. Inhibitors that target fusion
Wang Wei, Carol D. Weiss

7. HIV-1 entry inhibitors as microbicides
Clyde E. Hart, Tammy Evans-Strickfaden

8. Entry inhibition of HIV-1 subtype C isolates
Lynn Morris, Mia Coetzer, Elin S. Gray, Tonie Cilliers, Kabamba B. Alexandre, Penny L. Moore, James M. Binley

9. The utility of coreceptor typing in the clinic
Eoin Coakley

10. Future clinical prospects for entry inhibitors
Sonya L. Heath, J. Michael Kilby

11. Enfuvirtide: from basic science to FDA approval
Michael L. Greenberg

12. Targets for drug development — past and present
Roy M. Gulick

DRM-restrictions

Printing: not available
Clipboard copying: not available

Nyckelord: TECHNOLOGY & ENGINEERING / Biomedical TEC059000